Wockhardt Share Price Target 2024-2030 Fundamentals & Quarterly Results

Yes Bank Share Price Target 2024, 2025, 2026, 2027, 2028, 2029, 2030 Fundamentals & Quarterly Results – Wockhardt is a worldwide pharmaceutical and biotechnology company that produces disposable dosage forms, injectable drugs, biopharmaceutical drugs, oral drugs, topically administered medications(ointments or creams). Wockhardt Pharma Limited is an Indian healthcare and pharmaceutical company that was started in 1967.Multinational enterprise has a presence in 30 countries all over the world and on all continents.Wockhardt Share Price Target

Wockhardt Overview

WOCKPHARMA began more than 5 decades ago. Since that time we have been in the forefront of the business’s evolution; a path that has been characterized by development and establishment of itself as an international leader in the sector. In fact, it is this global reach which generates about 67-percent of annual income.

Company NameWockhardt
Listed atNSE & BSE
Head OfficeD-4 MIDC, Chikalthana
Aurangabad, 431006, India
Board Of Directors
  • Dr.Huzaifa Khorakiwala Executive Director
  • Dr.Habil Khorakiwala Founder Chairman
  • Mr.Aman Mehta Independent Director
  • Mr.Akhilesh Gupta Independent Director
  • Mrs.Tasneem Mehta Independent Director
  • Mr.Vinesh Kumar Jairath Independent Director
  • Mr.D S Brar Independent Director
  • Dr.Sanjaya Baru Independent Director
  • Dr.Murtaza Khorakiwala Managing Director
  • Ms.Zahabiya Khorakiwala Non Executive Director
Official Websitewockhardt.com

Also Check Yes Bank Share Price Target

Wockhardt Business Profile

The firm is one of the three major Indian generic companies in UK and the sixth largest supplier of generics in Ireland, present in both Retail and Hospital channels. Its Wepox mark is the bioequivalent of Erythropoetin (market share of 21%) and Methylcobalamin trademark is number 1 with (Methycobal share 26.7%).

Also Check Tata Elxsi Share Price Target

Global Presence

India, USA, UK, Ireland and France are fully operational for the Co. Russia, Brazil, Mexico, Vietnam, Philippines, Nigeria, Kenya, Ghana, Tanzania, Nepal, Uganda, Mauritius, Myanmar, Sri Lanka, Lebanon & Kuwait are some of the emerging markets where it markets some other products.

Also Check RBL Bank Share Price Target

Vaccine Manufacturing

A deal was struck between the UK Government and The Co. in order to fill and finish COVID-19 vaccines that were manufactured at CP Pharmaceuticals; a subsidiary company belonging to Wockhardt which hails from Wrexham, North Wales. According to the terms of the agreement, the company retains production capacity to enable it serve various vaccines to the UK Government among them being AZD1222 which was co-invented by Oxford University and licensed by AstraZeneca.

Also Check Marksans Pharma Share Price Target

Manufacturing Capabilities

The Company has arrayed a multi-technology capacity which is all-encompassing in producing all forms of dose forms ranging from sterile injections to lyophilised products by establishing an inter-calibrated network of instruments. There are about 14 dynamically operating factories stationed in various countries across the world specifically in India, Britain and America with highly proficient craftsmen guiding them everyday and conforming to Food and Drug Administration standards of America, European Medicine Agency as well as British Medicine and Health Product Regulatory Agency.

Also Check Union Bank Share Price Target

Strategic Partnerships

Wockhardt Bio AG – a subsidiary of the Company and Jiangxi Jemincare Group Company Limited, China is in partnership with Wockhardt, the manufacturer of an innovative antibiotic named Nafithromycin to which the latter holds a patent. In turn, a global vaccine programme (~ 150 mn doses annually) between companies CP Pharmaceuticals Limited (a subsidiary of the Company) and Serum Life Sciences UK has been initiated.

Also Check Mazagon Dock Share Price Target

WOCKPHARMA Hospitals

There are 6 super-speciality hospitals owned by Wockhardt Hospitals in different parts of Gujarat and Maharashtra state. The hospital has pioneered in clinical excellence by high-quality healthcare provision and innovative research in regenerative medicine field touching on Stem Cells and Growth Factor Concentrate (GFC) Therapy in Hair Regrowth, Aesthetics, Orthopaedics, and Chronic Wound Healing.

Also check South Indian Bank Share Price Target

Wockhardt Share Fundamentals & Quarterly Results

TermsValue
Market Cap₹ 8,238 Cr.
Current Price₹ 537
High / Low₹ 630 / 167
Stock P/E
Book Value₹ 219
Dividend Yield0.00 %
ROCE-1.70 %
ROE-13.4 %
Face Value₹ 5.00
Debt to equity0.70
Debt Capacity-0.14
Debt preceding year₹ 2,184 Cr.
Debt₹ 2,356 Cr.
Reserves₹ 3,282 Cr.
EPS₹ -30.2
EPS last year₹ -30.2
Pledged percentage52.9 %
FCF Prev Ann₹ 23.0 Cr.
EVEBITDA82.5
Industry PE30.7
PEG Ratio
Piotroski score3.00
Earnings yield-1.01 %
Sales growth 5Years-4.73 %

Also Check L&T Finance Share Price Target

Wockhardt Quarterly Results

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
Sales +854655595679699678644753701700
Expenses +742688611636654675628681664803
Operating Profit112-33-1643453167237-103
OPM %13%-5%-3%6%6%0%2%10%5%-15%
Other Income +2-16957-138-1-64024854
Interest80867370837679767773
Depreciation62596465665655555558
Profit before tax-28-347-96-230-105-193-118-35-87-180
Tax %107%10%22%10%3%-23%-15%-109%1%2%
Net Profit +2-311-75-207-102-237-136-73-86-177
EPS in Rs-0.49-17.91-4.65-13.12-6.66-14.44-9.30-5.34-5.76-11.02

ALso Check PCBL Share Price Target

WOCKPHARMA CAGR Report

10 Years5 Years3 YearsLast Year (TTM)
Compounded Sales Growth-5%-5%1%6%
Compounded Profit Growth-51%
Stock Price CAGR0%8%-2%217%
Return on Equity-1%0%-8%-13%

Also Check Himadri Share Price Target

Wockhardt Shareholding Pattern

Shareholder TypeMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Promoters +74.25%74.11%74.07%72.13%72.12%67.13%59.31%51.60%
FIIs +4.55%5.45%4.74%4.85%3.10%2.89%2.78%5.49%
DIIs +2.71%4.99%2.55%0.24%0.09%0.09%0.22%4.82%
Government +0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.01%
Public +18.49%15.45%18.64%22.78%24.69%29.89%37.70%38.06%
No. of Shareholders1,24,40399,7361,14,3381,17,3241,25,4881,72,4601,82,4931,46,138

Wockhardt Share Price Target 2024-2030 Forecast

YearInitial TargetMid-Year TargetYear-End Target
2024₹529.44₹660.8₹739.61
2025₹754₹709₹846
2026₹863₹811₹968
2027₹987₹928₹1108
2028₹1130₹1062₹1267
2029₹1292₹1214₹1450
2030₹1479₹1390₹1660

WOCKPHARMA Share Price Target 2025

MonthTarget
January₹754
February₹769
March₹784
April₹758
May₹733
June₹709
July₹737
August₹766
September₹797
October₹813
November₹829
December₹846

WOCKPHARMA Share Price Target 2026

MonthTarget
January₹863
February₹880
March₹898
April₹868
May₹839
June₹811
July₹843
August₹877
September₹912
October₹930
November₹949
December₹968

Wockhardt Share Price Target 2027

MonthTarget
January₹987
February₹1007
March₹1027
April₹993
May₹960
June₹928
July₹965
August₹1004
September₹1044
October₹1065
November₹1086
December₹1108

Wockhardt Share Price Target 2028

MonthTarget
January₹1130
February₹1153
March₹1176
April₹1137
May₹1099
June₹1062
July₹1104
August₹1148
September₹1194
October₹1218
November₹1242
December₹1267

Wockhardt Share Price Target 2029

MonthTarget
January₹1292
February₹1318
March₹1344
April₹1299
May₹1256
June₹1214
July₹1263
August₹1314
September₹1367
October₹1394
November₹1422
December₹1450

Wockhardt Share Price Target 2030

MonthTarget
January₹1479
February₹1509
March₹1539
April₹1488
May₹1438
June₹1390
July₹1446
August₹1504
September₹1564
October₹1595
November₹1627
December₹1660

Official Website –wockhardt.com

Leave a Comment